QualityStocksNewsBreaks Archives - Page 1209 of 1421

MondayNov 19, 2018 9:25 am

QualityStocksNewsBreaks – Cyberfort Software, Inc. (CYBF) Intends to Uplist to OTCQB Venture Market in Q1 2019

Cybersecurity technology company Cyberfort Software, Inc. (OTC: CYBF) this morning announced its plans to uplist to the OTCQB Venture Market in the first quarter of 2019. “Trading on the OTCQB will be another important milestone for CYBF and a key step in expanding our financial communication program,” Daniel Cattlin, CEO of CYBF, stated in the news release. “Uplisting from the Pink Sheets will help us provide greater transparency to existing and prospective shareholders while growing our exposure to a broader investing audience… These standards provide a strong baseline of transparency, as well as the technology and regulation to improve the…

FridayNov 16, 2018 3:19 pm

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Seeking Out Cultivation Facilities with Existing Infrastructure

Cannabis Strategic Ventures (OTC: NUGS) is on the lookout for grow facilities with existing infrastructure in states that have legalized cannabis as a supply shortage becomes imminent California. A recent article discussing the company reads, “Cannabis Strategic Ventures has already embarked on pre-acquisition due diligence for prospective cultivation properties located in states that have legalized cannabis. The company has identified several cannabis grow facilities in California and has begun analyzing these for possible acquisition. It is targeting several locations with areas exceeding 200,000 square feet that have existing cultivation infrastructure in place, since it wants to move into cultivation very…

FridayNov 16, 2018 3:13 pm

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Solidifies Market Position with Hempistry Investment

Hydroponics supply company Sugarmade (OTCQB: SGMD) has made a commitment to invest $1 million in Hempistry Inc., advancing its goal of producing ultra-high CBD-content hemp grown in Kentucky. A recent article discussing the company reads, “The investment in Hempistry is a strategic one for SGMD, as the U.S. industrial hemp market is forecast to grow to $1 billion in revenues in 2018. The expected compound annual growth rate (CAGR) for industrial hemp through 2022 in the U.S. alone is expected to be 14 percent. … Hempistry Inc. is a Nevada-based privately-held corporation focusing on the growth of ultra-high CBD industrial…

FridayNov 16, 2018 2:54 pm

QualityStocksNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Targets Canadian Medical and Recreational Markets

Vertically integrated Canadian cannabis company The Flowr Corporation (TSX.V: FLWR) obtained its sales license from Health Canada in August of this year, thereby permitting FLWR to sell to both the medical and the adult-use recreational markets. An article discussing the company reads, “The Flowr Corporation is headquartered in Markham, Ontario, and has production facilities in Kelowna, BC. It is constructing a flagship 85,000 square foot cultivation facility using proprietary growing systems and designs and engineered meet pharmaceutical quality production standards. It is currently operational at approximately 20 percent, with the remaining 80 percent scheduled to come online early in 2019. …

FridayNov 16, 2018 2:48 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Leveraging Agricultural Science and Innovation Experience to Provide Premium Cannabis

Green Hygienics Holdings (OTC: GRYN), a full-scope, premium cannabis company, is using its more than 25 years of experience in agricultural science and innovation to its advantage the cannabis industry. An article discussing the company reads, “Green Hygienics utilizes the science of hygienics to create the highest quality cannabis products for medical and recreational use. The company creates a controlled organic and pest-free environment that consistently produces higher yields and superior product. Green Hygienics utilizes technology that improves energy efficiency, uses 90-95 percent less water and does not require pesticides or fungicides. With over 25 years of experience in agricultural…

FridayNov 16, 2018 1:49 pm

QualityStocksNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Reviews Q3 2018 Financial Results and Double-Digit Revenue Growth, Provides Business Highlights

Global technology and value-added solutions group Net Element (NASDAQ: NETE) recently announced its financial results for the third quarter ended September 30, 2018 and provided an update on its strategic and operational initiatives. According to the update, the company’s net revenues were approximately $17.2 million for the three months ended September 30, 2018, up from approximately $14.9 million for the prior year. NETE attributes the increase as primarily driven by a growth in net revenues of approximately 19 percent, or $2.5 million, from its North American Transaction Solutions segment due to its acquisition of a transactional services portfolio and organic…

FridayNov 16, 2018 12:14 pm

QualityStocksNewsBreaks – Marijuana Company of America Inc. (MCOA) Issues Harvest Update for Joint Venture CBD Hemp Project in New Brunswick

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) with joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) issued an update on the harvest at the partners’ cannabinoid (“CBD”) hemp project in New Brunswick, Canada. According to the update, the 2018 cultivation comprised 125 acres contracted from four northeast New Brunswick farmers, and utilized three Health Canada approved cultivars with expected CBD content of 1.5 percent to 2.5 percent. “We want to thank the farmers for their creativity and willingness to find solutions to the challenges that arose as we worked through the…

FridayNov 16, 2018 11:31 am

QualityStocksNewsBreaks – DPW Holdings, Inc. (NYSE American: DPW) Reports Financial Results for Q3 2018

DPW Holdings (NYSE American: DPW) reported financial results for its third quarter ended September 30, 2018. According to the update, the company’s revenue increased 159 percent quarter-over-comparative-quarter, with DPW anticipating tripled revenues in 2018 as compared to 2017. “During the third quarter, we continued to build and monetize our diverse business,” DPW CEO and Chairman Milton “Todd” Ault, III stated in the news release. “Our 159 percent revenue increase reflects growth among our acquisitions in defense, power supply and hospitality. We will continue to foster these and other emerging businesses with the goal of increasing our rate of return.” To…

FridayNov 16, 2018 11:01 am

QualityStocksNewsBreaks – Six Six Five Energy, Inc. (SSOF) Highlights Q3 2018 Financial Results

Six Six Five Energy, Inc. (OTC: SSOF) late Thursday announced its financial results for the third quarter of 2018, including its sales and margin growth for the three months ended September 30, 2018, and an update on its audit. Among the highlights, the company recorded revenues of $2.7 million for the three-month period, marking a year-over-year increase of 47 percent. Similarly, the company’s net margins increased to 14 percent in the third quarter of 2018, as compared to six percent in the prior year period. “In the third quarter we worked on consolidating our business, and going forward we expect…

FridayNov 16, 2018 10:42 am

QualityStocksNewsBreaks – CytoDyn Inc.’s (CYDY) PRO 140 HIV Monotherapy Trial Data Selected for Presentation at CROI 2019

Biotechnology company CytoDyn (OTCQB: CYDY) today announced that data from its ongoing investigative trial of PRO 140 (leronlimab) as a single subcutaneous therapy in HIV-1 infected patients was accepted for a poster presentation at next year’s Conference on Retroviruses and Opportunistic Infections (“CROI”). Vice President, Clinical Operations at Amarex Clinical Research Dr. Kush Dhody will present the abstract, “PRO 140 SC: Long-acting, Single-agent Maintenance Therapy for HIV-1 Infection,” at CROI 2019, to be held in Seattle March 4-7, 2019. “We are highly encouraged by the recently reported data from our monotherapy trial for patients receiving once-weekly injections of PRO 140…

Site Search

Company Search

Category: QualityStocksNewsBreaks